We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: Global COVID-19 Saliva-Based Screening Market to Continue Growing due to Ease of Use and Shorter Test-To-Result (Photo courtesy of Persistence Market Research)

Global COVID-19 Saliva-Based Screening Market to Continue Growing Due to Ease of Use and Shorter Test-to-Result

The global COVID-19 saliva-based screening market was valued at over USD 1.7 billion in 2020 and is gaining traction, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. More...
07 Sep 2021
Illustration

Global Hematology Testing Instrument Market Driven by Growing Demand for Preventive Diagnosis and Treatment Monitoring

The global hematology testing instrument market is witnessing high growth due to technological advances in disease diagnosis and rise in demand for preventive diagnosis and treatment monitoring. More...
26 Aug 2021
Illustration

Global Urinalysis Market Projected to Reach Nearly USD 5 Billion by 2026

The global urinalysis market is projected to grow at a CAGR of 7.2% from USD 3.5 billion in 2021 to nearly USD 4.9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases, and growing adoption of POC diagnostic tests. More...
24 Aug 2021
Image: DELFI blood test identifies lung cancer using artificial intelligence to detect unique patterns in the fragmentation of DNA shed from cancer cells compared to normal profiles (Photo courtesy of Carolyn Hruban)

Novel Artificial Intelligence (AI) Blood Test Can Detect Over 90% of Lung Cancers

A novel blood test identifies lung cancer using artificial intelligence (AI) to detect unique patterns in the fragmentation of DNA shed from cancer cells compared to normal profiles. More...
24 Aug 2021
Illustration

Global Point of Care Diagnostics Market Expected to Reach USD 71 Billion in 2027

The global point of care diagnostics market is estimated to register a CAGR of 11.8% from 2019-2027 and grow from USD 26.60 billion in 2018 to USD 70.89 billion in 2027, driven by the introduction of new point-of-care testing (POCT) products that are aimed at delivering inexpensive care at facilities located at the closest-possible distances from the patients’ location. More...
22 Aug 2021
Image: Illumina headquarters in San Diego, California (Photo courtesy of Illumina)

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Illumina, Inc. (San Diego, CA, USA) has acquired GRAIL (Menlo Park, CA, USA), a healthcare company focused on life-saving early detection of multiple cancers. More...
20 Aug 2021
Illustration

BioCheck Acquires IVD Company DRG International

BioCheck Inc. (San Francisco, CA, USA) has acquired DRG International Inc. (Springfield, NJ, USA), a manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries. More...
20 Aug 2021
New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Automated PCR Setup
ESTREAM


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.